Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,118

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gf-blends-recalls-truly-aip-all-purpose-flour-and-bread-mix-and-eat-gangster-flat-bread-pizza-mixPublished September 18, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 20, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall Terminated Historical recordClass II

Baclofen USP (Micronized) for prescription compounding, packaged in a) 25g (NDC 58597-8004-4); b)100g (NDC 58597-8004-6); c) 500g (NDC 58597-8004-7); d) 1000g (NDC 58597-8004-8), RX only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.

by American Pharmaceutical Ingredients LLC

Reason: CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Anastrozole USP for prescription compounding, packaged in a) 1g ( NDC 58597-8080-1), b) 5g (NDC 58597-8080-2), c) 25g (NDC 58597-8080-4), RX only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.

by American Pharmaceutical Ingredients LLC

Reason: CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Amitriptyline HCl USP for prescription compounding , packaged in a) 25 g (NDC 58597-8003-4); b) 100 g (NDC 58597-8003-6); c) 500 g (NDC 58597-8003-7), d) 1000 g (NDC 58597-8003-8), RX only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.

by American Pharmaceutical Ingredients LLC

Reason: CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02

by Nostrum Laboratories Inc

Reason: Presence of Foreign Tablets/Capsules
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nicardipine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dexamethasone Sodium Phosphate added to 5% Dextrose in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Rocuronium Bromide in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methadone HCl Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Meperidine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Esmolol HCl in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dexamethasone Sodium Phosphate added to 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Vecuronium Bromide in Sterile Water for Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Neostigmine Methylsulfate Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Labetalol HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nicardipine HCl in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ropivacaine HCl Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HYDROmorphone HCl in 5% Dextrose in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atropine Sulfate Injection in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glycopyrrolate in all strengths, all doses, and all packaging.

by PharMEDium Services, LLC

Reason: Lack of sterility assurance.
Published: February 28, 2018
Distribution: Nationwide

View recall →

Data last updated: September 20, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.